标题
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 5, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-08-17
DOI
10.3389/fonc.2015.00186
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor
- (2015) Kenichi Kohashi et al. HUMAN PATHOLOGY
- Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial
- (2014) Alexia Buzzonetti et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- ConsistentSMARCB1homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material
- (2014) Francois Le Loarer et al. GENES CHROMOSOMES & CANCER
- Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis
- (2014) Li Li et al. HUMAN PATHOLOGY
- Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
- (2014) Hui Jun Lim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
- (2014) Yoshinori Imura et al. Molecular Cancer
- Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
- (2014) Daniel Pink et al. ONCOLOGY
- ERG Expression in Epithelioid Sarcoma
- (2013) Markku Miettinen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epithelioid Sarcoma: Need for a Multimodal Approach to Maximize the Chances of Curative Conservative Treatment
- (2013) Antonin Levy et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer--Mechanisms and Potential Therapeutic Insights
- (2013) X. Wang et al. CLINICAL CANCER RESEARCH
- SMARCB1expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels
- (2013) Gergő Papp et al. GENES CHROMOSOMES & CANCER
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression
- (2013) Kenichi Kohashi et al. MODERN PATHOLOGY
- ERG and FLI1 protein expression in epithelioid sarcoma
- (2013) David L Stockman et al. MODERN PATHOLOGY
- SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
- (2013) M. Brenca et al. MOLECULAR CANCER THERAPEUTICS
- Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis
- (2013) J Darr et al. ONCOGENE
- Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma
- (2013) E Sokolowski et al. ONCOGENE
- Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
- (2013) E L Mora-Blanco et al. ONCOGENE
- Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
- (2013) Simon Wöhrle et al. PLoS One
- High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
- (2013) Makoto Emori et al. PLoS One
- Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate
- (2012) P. Penot et al. BRITISH JOURNAL OF DERMATOLOGY
- Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation
- (2012) Yoo-Kyung Lee et al. CANCER SCIENCE
- A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
- (2012) Ryan S. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma
- (2012) Gergő Papp et al. MODERN PATHOLOGY
- Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
- (2012) Lisa M Sullivan et al. MODERN PATHOLOGY
- Role of Palliative Chemotherapy in Advanced Epithelioid Sarcoma
- (2011) Robin L. Jones et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma
- (2011) Xianbiao Xie et al. CLINICAL CANCER RESEARCH
- A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites
- (2011) Costantino Errani et al. GENES CHROMOSOMES & CANCER
- E-Cadherin/β-Catenin Complex and the Epithelial Barrier
- (2011) Xinrui Tian et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Epithelioid Sarcoma and Unclassified Sarcoma with Epithelioid Features: Clinicopathological Variables, Molecular Markers, and a New Experimental Model
- (2011) A. Sakharpe et al. ONCOLOGIST
- A Case Report of Complete Remission of Pulmonary Metastases From Epithelioid Sarcoma to Navelbine Chemotherapy
- (2010) Zeeshan Tariq et al. AMERICAN JOURNAL OF THERAPEUTICS
- Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells
- (2010) Jeong-Ran Park et al. JOURNAL OF HEPATOLOGY
- Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare
- (2010) Michael J Cascio et al. MODERN PATHOLOGY
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
- (2010) Zainab Jagani et al. NATURE MEDICINE
- Epithelioid Sarcoma
- (2009) Laila Chbani et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- INI1 and GLUT-1 Expression in Epithelioid Sarcoma and Its Cutaneous Neoplastic and Nonneoplastic Mimics
- (2009) Jared M Orrock et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Primary Epithelioid Sarcoma of Bone
- (2009) Delphine Raoux et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma
- (2009) Jason L. Hornick et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Oncogenesis Caused by Loss of the SNF5 Tumor Suppressor Is Dependent on Activity of BRG1, the ATPase of the SWI/SNF Chromatin Remodeling Complex
- (2009) X. Wang et al. CANCER RESEARCH
- Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER Database
- (2009) Muhammad Umar Jawad et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma
- (2009) Makiko Hoshino et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The SWI/SNF complex and cancer
- (2009) D Reisman et al. ONCOGENE
- New insights of epithelial-mesenchymal transition in cancer metastasis
- (2008) Yadi Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Epithelioid sarcoma: the University of Washington experience
- (2008) Patrick S. Wolf et al. AMERICAN JOURNAL OF SURGERY
- The cell-cell adhesion molecule E-cadherin
- (2008) F. van Roy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor
- (2008) Kenichi Kohashi et al. HUMAN PATHOLOGY
- Epidermal Growth Factor Receptor Expression and Mutational Analysis in Synovial Sarcomas and Malignant Peripheral Nerve Sheath Tumors
- (2008) H. Tawbi et al. ONCOLOGIST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started